ArticleTargeted oncology2025

Population Exposure-Response Efficacy Analysis of Elranatamab (PF-06863135) in Patients with Multiple Myeloma.

Hoi-Kei Lon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.